Commentary: Fear not the rise of the machines.

J Thorac Cardiovasc Surg

Department of Cardiovascular and Thoracic Surgery, UT Southwestern Medical Center, Dallas, Tex. Electronic address:

Published: August 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2020.05.105DOI Listing

Publication Analysis

Top Keywords

commentary fear
4
fear rise
4
rise machines
4
commentary
1
rise
1
machines
1

Similar Publications

Article Synopsis
  • The text reviews the impact of Covid-19 on the mental health and well-being of pregnant women during the perinatal period, analyzing 42 empirical studies published between December 2019 and September 2021.
  • It identifies overarching themes such as "Impact" and "Emotional Impact," highlighting various factors like demographic influences, socio-economic status, and the quality of maternity service delivery that affect maternal mental health during the pandemic.
  • While there is evidence of increased risk for perinatal mental illness compared to pre-pandemic levels, many studies didn’t find a significant jump in prevalence, stressing the importance of understanding individual risk and protective factors in their specific contexts.
View Article and Find Full Text PDF

Pain Neuroscience Education: Teaching People About Pain.

J Pain Palliat Care Pharmacother

September 2024

Director of Membership, Functional Medicine Pharmacist Alliance, Sherman, TX, USA.

Chronic pain is an ever-increasing global challenge, and few strategies have been shown to significantly alter this trajectory, and a pure pharmaceutical approach, especially opioids, is not the answer. To truly impact a person with chronic pain's life, current best-evidence supports changing their cognitions (how they think about their pain), moving more, and calming the peripheral and central nervous system, including non-pharmacological strategies. All healthcare providers, however, must use a unified strategy regardless of their professional designation, skillset, and clinical setting.

View Article and Find Full Text PDF

It is thirty years since the BRCA1 and BRCA2 genes were discovered and genetic testing for BRCA1 and BRCA2 was introduced. Despite increasing awareness of the genetic basis of cancer and our evolving knowledge of effective means of prevention, screening, and treatment for hereditary breast and ovarian cancers, genetic testing is underutilized, and most mutation carriers remain unidentified. In this commentary, we explore possible reasons for why this might be so.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!